南美注射笔市场预测至 2028 年 - COVID-19 影响和区域分析(按类型(一次性注射笔和可重复使用注射笔)、治疗(糖尿病、生长激素治疗、自身免疫性疾病、生育力、癌症和其他治疗)和结束用户(医院和诊所、家庭护理等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 131    |    Report Code: BMIRE00028202    |    Category: Life Sciences

South America Injection Pen Market

南美注射笔市场预计将从2022年的23.8984亿美元增长到2028年的34.6789亿美元。预计2022年至2028年的复合年增长率为6.4%。< /strong>

 

加强南美注射笔市场的战略发展

 

注射笔市场的特点是市场参与者众多。为了增加市场份额,市场参与者采取各种策略,例如产品发布、区域扩张和技术进步。领先企业投资研发以开发先进技术并获得更多收入。

下面提到了与注射笔相关的一些最新进展:

2022 年 5 月,FDA 批准了礼来公司的 Mounjaro 注射液,这是第一个也是唯一一个葡萄糖依赖性促胰岛素多肽 (GIP) 和胰高血糖素样肽 1 (GLP-1) 受体激动剂,用于治疗 2 型糖尿病成年人。 Mounjaro 有六种剂量(2.5 毫克、5 毫克、7.5 毫克、10 毫克、12.5 毫克和 15 毫克),采用礼来公司完善的自动注射笔,配有预装隐藏针头。

2022 年 1 月,SHL Medical 与 Innovation Zed 合作开发互联笔式注射器解决方案。它推出了 InsulCheck DOSE,这是一种连接的附加设备,可将传统笔式注射器转变为智能解决方案,以支持疾病管理方案的监测。

2021 年 5 月,礼来公司与领先的糖尿病技术公司为糖尿病患者集成互联胰岛素笔解决方案。公司与四家公司签署战略国际协议——DexCom, Inc.;格洛克公司;我的迪亚比医疗保健;

因此,所有上述近期发展正在推动南美注射笔市场的发展。

span>

 

南美注射笔市场概况

 

南美洲的注射笔市场分为巴西、阿根廷和南美洲其他地区。南美注射笔市场的增长归因于糖尿病和不孕症发病率的增加以及主要市场参与者开展的产品开发活动。根据国际糖尿病联盟 (IDF) 的数据,约 1680 万名 20-79 岁的人患有糖尿病,预计到 2045 年这一数字将增加 55%。约 90% 的糖尿病诊断为 2 型糖尿病。此外,根据 IDF 的数据,巴西 0-14 岁儿童和青少年在全球 1 型糖尿病总体中排名第三,有 55,500 例病例。 BIOMM是一家总部位于巴西的生物制药公司,是全球第四大胰岛素生产商;它是该国最大的生产商。 2021 年 7 月,BIOMM 宣布与 Nemera 签署商业化协议,销售 Advapen 可重复使用笔式注射器,用于用 Glargilin 胰岛素治疗糖尿病。 BIOMM 将以 Lifepen 商品名在巴西市场销售该产品。

 

南美注射笔市场收入及预测2028 年(百万美元)

南美注射笔市场细分

南美注射笔市场根据类型、疗法、最终用户和国家/地区进行细分。根据类型,注射笔市场分为一次性注射笔和可重复使用注射笔。一次性注射笔细分市场在 2022 年占据了更大的市场份额。

 

根据治疗,南美注射笔市场细分为< span>糖尿病治疗、生长激素治疗、自身免疫性疾病治疗、生育治疗、癌症治疗等。糖尿病治疗细分市场在 2022 年占据最大市场份额。

  ;

根据最终用户,南美注射笔市场分为医院和医疗机构。诊所、家庭护理等。家庭护理细分市场在 2022 年占据最大市场份额。

 

根据国家/地区,南美注射笔市场分为巴西、阿根廷,以及 SAM 的其他国家。巴西在 2022 年占据市场主导地位。

 

阿斯利康公司 (AstraZeneca Plc)、碧迪金森公司 (Becton Dickinson and Co)、礼来公司 (Eli Lilly and Co)、Gerresheimer AG、Haselmeier GmbH、默克 (Merck) KGaA、Novo Nordisk AS、Owen Mumford Ltd、Sanofi SA 和 Teva Pharmaceutical Industries Ltd 是南美注射笔市场的领先公司。



South America Injection Pen Strategic Insights

Strategic insights for South America Injection Pen involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-america-injection-pen-market-strategic-framework.webp
Get more information on this report

South America Injection Pen Report Scope

Report Attribute Details
Market size in 2022 US$ 2,389.84 Million
Market Size by 2028 US$ 3,467.89 Million
Global CAGR (2022 - 2028) 6.4%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 类型
  • 一次性注射笔
  • 可重复使用注射笔
By 治疗
  • 糖尿病
  • 生长激素治疗
  • 自身免疫性疾病
  • 生育
  • 癌症
  • 其他治疗
By 最终用户
  • 医院和诊所
  • 家庭护理
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • AstraZeneca Plc
  • Becton Dickinson and Co
  • Eli Lilly and Co
  • Gerresheimer AG
  • Haselmeier GmbH
  • Merck KGaA
  • Novo Nordisk AS
  • Owen Mumford Ltd
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd
  • Get more information on this report

    South America Injection Pen Regional Insights

    The regional scope of South America Injection Pen refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-america-injection-pen-market-geography.webp
    Get more information on this report

    The List of Companies - South America Injection Pen Market

    1. AstraZeneca Plc
    2. Becton Dickinson and Co
    3. Eli Lilly and Co
    4. Gerresheimer AG
    5. Haselmeier GmbH
    6. Merck KGaA
    7. Novo Nordisk AS
    8. Owen Mumford Ltd
    9. Sanofi SA
    10. Teva Pharmaceutical Industries Ltd
    Frequently Asked Questions
    How big is the South America Injection Pen Market?

    The South America Injection Pen Market is valued at US$ 2,389.84 Million in 2022, it is projected to reach US$ 3,467.89 Million by 2028.

    What is the CAGR for South America Injection Pen Market by (2022 - 2028)?

    As per our report South America Injection Pen Market, the market size is valued at US$ 2,389.84 Million in 2022, projecting it to reach US$ 3,467.89 Million by 2028. This translates to a CAGR of approximately 6.4% during the forecast period.

    What segments are covered in this report?

    The South America Injection Pen Market report typically cover these key segments-

  • 类型 (一次性注射笔, 可重复使用注射笔)
  • 治疗 (糖尿病, 生长激素治疗, 自身免疫性疾病, 生育, 癌症, 其他治疗)
  • 最终用户 (医院和诊所, 家庭护理)
  • What is the historic period, base year, and forecast period taken for South America Injection Pen Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Injection Pen Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in South America Injection Pen Market?

    The South America Injection Pen Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • AstraZeneca Plc
  • Becton Dickinson and Co
  • Eli Lilly and Co
  • Gerresheimer AG
  • Haselmeier GmbH
  • Merck KGaA
  • Novo Nordisk AS
  • Owen Mumford Ltd
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd
  • Who should buy this report?

    The South America Injection Pen Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South America Injection Pen Market value chain can benefit from the information contained in a comprehensive market report.